{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T04:20:09Z","timestamp":1772166009253,"version":"3.50.1"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,8,4]],"date-time":"2023-08-04T00:00:00Z","timestamp":1691107200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,8,4]],"date-time":"2023-08-04T00:00:00Z","timestamp":1691107200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Universit\u00e4tsklinikum Carl Gustav Carus Dresden an der Technischen Universit\u00e4t Dresden"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med Inform Decis Mak"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>About 2% of the German population are affected by psoriasis. A growing number of cost-intensive systemic treatments are available. Surveys have shown high proportions of patients with moderate to severe psoriasis are not adequately treated despite a high disease burden. Digital therapy recommendation systems (TRS) may help implement guideline-based treatment. However, little is known about the acceptance of such clinical decision support systems (CDSSs). Therefore, the aim of the study was to access the acceptance of a prototypical TRS demonstrator.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Three scenarios (potential test patients with psoriasis but different sociodemographic and clinical characteristics, previous treatments, desire to have children, and multiple comorbidities) were designed in the demonstrator. The TRS demonstrator and test patients were presented to a random sample of 76 dermatologists attending a national dermatology conference in a cross-sectional face-to-face survey with case vignettes. The dermatologist were asked to rate the demonstrator by system usability scale (SUS), whether they would use it for certain patients populations and barriers of usage. Reasons for potential usage of the TRS demonstrator were tested via a Poisson regression with robust standard errors.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Acceptance of the TRS was highest for patients eligible for systemic therapy (82%). 50% of participants accepted the system for patients with additional comorbidities and 43% for patients with special subtypes of psoriasis. Dermatologists in the outpatient sector or with many patients per week were less willing to use the TRS for patients with special psoriasis-subtypes. Dermatologists rated the demonstrator as acceptable with an mean SUS of 76.8. Participants whose SUS was 10 points above average were 27% more likely to use TRS for special psoriasis-subtypes. The main barrier in using the TRS was time demand (47.4%). Participants who perceived time as an obstacle were 22.3% less willing to use TRS with systemic therapy patients. 27.6% of physicians stated that they did not understand exactly how the recommendation was generated by the TRS, with no effect on the preparedness to use the system.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>The considerably high acceptance and the preparedness to use the psoriasis CDSS suggests that a TRS appears to be implementable in routine healthcare and may improve clinical care. Main barrier is the additional time demand posed on dermatologists in a busy clinical setting. Therefore, it will be a major challenge to identify a limited set of variables that still allows a valid recommendation with precise prediction of the patient-individual benefits and harms.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12911-023-02246-9","type":"journal-article","created":{"date-parts":[[2023,8,4]],"date-time":"2023-08-04T02:01:38Z","timestamp":1691114498000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Acceptance of a digital therapy recommender system for psoriasis"],"prefix":"10.1186","volume":"23","author":[{"given":"Lisa","family":"Graf","sequence":"first","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8933-643X","authenticated-orcid":false,"given":"Falko","family":"Tesch","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5844-4761","authenticated-orcid":false,"given":"Felix","family":"Gr\u00e4\u00dfer","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6004-2670","authenticated-orcid":false,"given":"Lorenz","family":"Harst","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4049-9120","authenticated-orcid":false,"given":"Doreen","family":"Siegels","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0264-0960","authenticated-orcid":false,"given":"Jochen","family":"Schmitt","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7457-6481","authenticated-orcid":false,"given":"Susanne","family":"Abraham","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2023,8,4]]},"reference":[{"key":"2246_CR1","doi-asserted-by":"publisher","first-page":"2199","DOI":"10.1001\/jama.2018.17163","volume":"320","author":"EH Shortliffe","year":"2018","unstructured":"Shortliffe EH, Sep\u00falveda MJ. Clinical decision support in the era of Artificial Intelligence. JAMA. 2018;320:2199. https:\/\/doi.org\/10.1001\/jama.2018.17163.","journal-title":"JAMA"},{"key":"2246_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2017\/8659460","volume":"2017","author":"F Gr\u00e4\u00dfer","year":"2017","unstructured":"Gr\u00e4\u00dfer F, Beckert S, K\u00fcster D, Schmitt J, Abraham S, Malberg H, et al. Therapy decision support based on Recommender System Methods. J Healthc Eng. 2017;2017:1\u201311. https:\/\/doi.org\/10.1155\/2017\/8659460.","journal-title":"J Healthc Eng"},{"key":"2246_CR3","first-page":"159","volume":"1","author":"G Kong","year":"2008","unstructured":"Kong G, Xu D-L, Yang J-B. Clinical decision support Systems: a review on knowledge representation and inference under uncertainties. Int J Comput Intell Syst. 2008;1:159\u201367.","journal-title":"Int J Comput Intell Syst"},{"key":"2246_CR4","first-page":"206","volume":"2014","author":"JH Chen","year":"2014","unstructured":"Chen JH, Altman RB. Automated physician order recommendations and outcome predictions by data-mining electronic medical records. AMIA Jt Summits Transl Sci Proc AMIA Jt Summits Transl Sci. 2014;2014:206\u201310.","journal-title":"AMIA Jt Summits Transl Sci Proc AMIA Jt Summits Transl Sci"},{"key":"2246_CR5","doi-asserted-by":"publisher","first-page":"e24","DOI":"10.2196\/medinform.8912","volume":"6","author":"S Khairat","year":"2018","unstructured":"Khairat S, Marc D, Crosby W, Al Sanousi A. Reasons for Physicians not adopting clinical decision support Systems: critical analysis. JMIR Med Inform. 2018;6:e24. https:\/\/doi.org\/10.2196\/medinform.8912.","journal-title":"JMIR Med Inform"},{"key":"2246_CR6","unstructured":"Michalek IM, Loring B, John SM. World Health Organization. Global report on psoriasis. 2016."},{"key":"2246_CR7","doi-asserted-by":"publisher","unstructured":"Wu JJ, Kavanaugh A, Lebwohl MG, Gniadecki R, Merola JF. Psoriasis and metabolic syndrome: implications for the management and treatment of psoriasis. J Eur Acad Dermatol Venereol. 2022 Mar 2. doi: https:\/\/doi.org\/10.1111\/jdv.18044. Epub ahead of print. PMID: 35238067.","DOI":"10.1111\/jdv.18044"},{"key":"2246_CR8","doi-asserted-by":"publisher","first-page":"819","DOI":"10.2340\/00015555-2657","volume":"97","author":"A Egeberg","year":"2017","unstructured":"Egeberg A, Thyssen J, Jensen P, Gislason G, Skov L. Risk of myocardial infarction in patients with psoriasis and psoriatic arthritis: a Nationwide Cohort Study. Acta Derm Venereol. 2017;97:819\u201324. https:\/\/doi.org\/10.2340\/00015555-2657.","journal-title":"Acta Derm Venereol"},{"key":"2246_CR9","doi-asserted-by":"publisher","first-page":"1612","DOI":"10.1016\/j.jid.2017.06.001","volume":"137","author":"M Lebwohl","year":"2017","unstructured":"Lebwohl M. Does treatment of Psoriasis Reduce Cardiovascular Comorbidities? J Invest Dermatol. 2017;137:1612\u20133. https:\/\/doi.org\/10.1016\/j.jid.2017.06.001.","journal-title":"J Invest Dermatol"},{"issue":"7","key":"2246_CR10","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1111\/ddg.14507","volume":"19","author":"A Nast","year":"2021","unstructured":"Nast A, Altenburg A, Augustin M, Boehncke WH, H\u00e4rle P, Klaus J, Koza J, et al. German S3-Guideline on the treatment of Psoriasis vulgaris, adapted from EuroGuiDerm - Part 2: treatment monitoring and specific clinical or comorbid situations. J Dtsch Dermatol Ges. 2021;19(7):1092\u2013115. https:\/\/doi.org\/10.1111\/ddg.14507.","journal-title":"J Dtsch Dermatol Ges"},{"key":"2246_CR11","volume-title":"Psoriasis: assessment and management","author":"National Institute for Health and Care Excellence (Great Britain)","year":"2017","unstructured":"National Institute for Health and Care Excellence (Great Britain). Psoriasis: assessment and management. London: National Institute for Health and Care Excellence (NICE); 2017."},{"key":"2246_CR12","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1111\/ddg.14387","volume":"19","author":"AC Pilz","year":"2021","unstructured":"Pilz AC, Zink A, Schielein MC, Hell K, Romer K, Hillmann E, et al. Despite large choice of effective therapies: individuals with psoriasis still seem undertreated. JDDG J Dtsch Dermatol Ges. 2021;19:1003\u201311. https:\/\/doi.org\/10.1111\/ddg.14387.","journal-title":"JDDG J Dtsch Dermatol Ges"},{"key":"2246_CR13","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1111\/jdv.14811","volume":"32","author":"MC Schielein","year":"2018","unstructured":"Schielein MC, Tizek L, Rotter M, Konstantinow A, Biedermann T, Zink A. Guideline-compliant prescription of biologicals and possible barriers in dermatological practices in Bavaria. J Eur Acad Dermatol Venereol. 2018;32:978\u201384. https:\/\/doi.org\/10.1111\/jdv.14811.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"2246_CR14","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1111\/bjd.17421","volume":"180","author":"ZZN Yiu","year":"2019","unstructured":"Yiu ZZN, Sorbe C, Lunt M, Rustenbach SJ, K\u00fchl L, Augustin M, et al. Development and validation of a multivariable risk prediction model for serious infection in patients with psoriasis receiving systemic therapy. Br J Dermatol. 2019;180:894\u2013901. https:\/\/doi.org\/10.1111\/bjd.17421.","journal-title":"Br J Dermatol"},{"key":"2246_CR15","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1111\/j.1365-2753.2008.00971.x","volume":"14","author":"A Nast","year":"2008","unstructured":"Nast A, Erdmann R, Pathirana D, Rzany B. Translating psoriasis treatment guidelines into clinical practice - the need for educational interventions and strategies for broad dissemination: implementation of psoriasis guidelines. J Eval Clin Pract. 2008;14:803\u20136. https:\/\/doi.org\/10.1111\/j.1365-2753.2008.00971.x.","journal-title":"J Eval Clin Pract"},{"key":"2246_CR16","doi-asserted-by":"publisher","first-page":"2002","DOI":"10.1111\/jdv.13150","volume":"29","author":"PCM Kerkhof","year":"2015","unstructured":"Kerkhof PCM, Reich K, Kavanaugh A, Bachelez H, Barker J, Girolomoni G, et al. Physician perspectives in the management of psoriasis and psoriatic arthritis: results from the population-based multinational Assessment of Psoriasis and Psoriatic Arthritis survey. J Eur Acad Dermatol Venereol. 2015;29:2002\u201310. https:\/\/doi.org\/10.1111\/jdv.13150.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"2246_CR17","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.1001\/jamadermatol.2013.5264","volume":"149","author":"AW Armstrong","year":"2013","unstructured":"Armstrong AW, Robertson AD, Wu J, Schupp C, Lebwohl MG, Undertreatment. Treatment Trends, and treatment dissatisfaction among patients with psoriasis and psoriatic arthritis in the United States: findings from the National Psoriasis Foundation surveys, 2003\u20132011. JAMA Dermatol. 2013;149:1180. https:\/\/doi.org\/10.1001\/jamadermatol.2013.5264.","journal-title":"JAMA Dermatol"},{"key":"2246_CR18","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1016\/j.adengl.2018.06.021","volume":"109","author":"JL L\u00f3pez-Estebaranz","year":"2018","unstructured":"L\u00f3pez-Estebaranz JL, de la Cueva-Dobao P, de la Torre Fraga C, Gal\u00e1n Guti\u00e9rrez M, Gonz\u00e1lez Guerra E, Mollet S\u00e1nchez J, et al. Management of moderate to severe psoriasis in routine clinical practice in spanish hospitals. Actas Dermo-Sifiliogr\u00e1ficas Engl Ed. 2018;109:631\u201342. https:\/\/doi.org\/10.1016\/j.adengl.2018.06.021.","journal-title":"Actas Dermo-Sifiliogr\u00e1ficas Engl Ed"},{"key":"2246_CR19","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1080\/10447310802205776","volume":"24","author":"A Bangor","year":"2008","unstructured":"Bangor A, Kortum PT, Miller JT. An empirical evaluation of the System Usability Scale. Int J Hum-Comput Interact. 2008;24:574\u201394. https:\/\/doi.org\/10.1080\/10447310802205776.","journal-title":"Int J Hum-Comput Interact"},{"key":"2246_CR20","doi-asserted-by":"publisher","first-page":"e13117","DOI":"10.2196\/13117","volume":"21","author":"L Harst","year":"2019","unstructured":"Harst L, Lantzsch H, Scheibe M. Theories Predicting end-user Acceptance of Telemedicine Use: systematic review. J Med Internet Res. 2019;21:e13117. https:\/\/doi.org\/10.2196\/13117.","journal-title":"J Med Internet Res"},{"key":"2246_CR21","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1093\/aje\/kwh090","volume":"159","author":"G Zou","year":"2004","unstructured":"Zou G. A modified Poisson Regression Approach to prospective studies with Binary Data. Am J Epidemiol. 2004;159:702\u20136. https:\/\/doi.org\/10.1093\/aje\/kwh090.","journal-title":"Am J Epidemiol"},{"key":"2246_CR22","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1353\/cpr.2012.0016","volume":"6","author":"SF Casta\u00f1eda","year":"2012","unstructured":"Casta\u00f1eda SF, Holscher J, Mumman MK, Salgado H, Keir KB, Foster-Fishman PG, et al. Dimensions of Community and Organizational Readiness for Change. Prog Community Health Partnersh Res Educ Action. 2012;6:219\u201326. https:\/\/doi.org\/10.1353\/cpr.2012.0016.","journal-title":"Prog Community Health Partnersh Res Educ Action"},{"key":"2246_CR23","unstructured":"KBV Kassen\u00e4rztliche. Bundesvereinigung. Statistische Informationen aus dem Bundesarztregister. 2020."},{"key":"2246_CR24","doi-asserted-by":"publisher","unstructured":"Zander N, Naatz M, Augustin M, Langenbruch A, Topp J, Mrowietz U, et al. Determinants of costs and benefits in psoriasis routine care: results from a cross-sectional nationwide study in Germany. J Eur Acad Dermatol Venereol. 2021;35. https:\/\/doi.org\/10.1111\/jdv.16807.","DOI":"10.1111\/jdv.16807"},{"key":"2246_CR25","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1111\/jdv.14543","volume":"32","author":"D Jungen","year":"2018","unstructured":"Jungen D, Augustin M, Langenbruch A, Zander N, Reich K, Str\u00f6mer K, et al. Cost-of-illness of psoriasis - results of a german cross-sectional study. J Eur Acad Dermatol Venereol. 2018;32:174\u201380. https:\/\/doi.org\/10.1111\/jdv.14543.","journal-title":"J Eur Acad Dermatol Venereol"}],"container-title":["BMC Medical Informatics and Decision Making"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12911-023-02246-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12911-023-02246-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12911-023-02246-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,19]],"date-time":"2023-11-19T10:16:07Z","timestamp":1700388967000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmedinformdecismak.biomedcentral.com\/articles\/10.1186\/s12911-023-02246-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,4]]},"references-count":25,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["2246"],"URL":"https:\/\/doi.org\/10.1186\/s12911-023-02246-9","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-1658956\/v1","asserted-by":"object"}]},"ISSN":["1472-6947"],"issn-type":[{"value":"1472-6947","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,4]]},"assertion":[{"value":"15 May 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 July 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 August 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors confirm that all methods were performed in accordance with relevant guidelines and regulations. Since this is a survey of physicians, obtaining an ethical consent is not required. In this context, as long as the data analysis is only anonymous, a consultation with the ethics committee is not required. The ethics committee at the Technical University of Dresden waived the need for ethics approval and informed consent to participate (PD Dr. med. Hermann Theilen, chair of the ethics committee, ethics committee at the Technical University of Dresden, Fetscherstr. 74 01307 Dresden, Germany). See appendix: \u201cWaiver Ethics Committee_Verzichtserkl\u00e4rung Ethikvotum\u201d.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"150"}}